Surveillance guidelines after removal of colorectal adenomatous polyps.
about
Expert opinions and scientific evidence for colonoscopy key performance indicatorsNon-neoplastic findings at colonoscopy after positive faecal occult blood testing: data from the English Bowel Cancer Screening Programme.Antioxidants in the chemoprevention of colorectal cancer and colorectal adenomas in the general population: a systematic review and meta-analysis.Clinical outcomes using a faecal immunochemical test for haemoglobin as a first-line test in a national programme constrained by colonoscopy capacityAdenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study.AMACR is associated with advanced pathologic risk factors in sporadic colorectal adenomas.Using resource modelling to inform decision making and service planning: the case of colorectal cancer screening in Ireland.Clinical correlates of health preference and generic health-related quality of life in patients with colorectal neoplasms.The impact of age, sex and socioeconomic deprivation on outcomes in a colorectal cancer screening programme.Genetic variation in the base excision repair pathway, environmental risk factors, and colorectal adenoma risk.22-year longitudinal study of repetitive colonoscopy in patients with a family history of colorectal cancer.Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programmeLack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenomaImmunohistochemical Expression of ki-67 and p53 in Colorectal Adenomas: A Clinicopathological Study.Awareness of postpolypectomy surveillance guidelines: a nationwide survey of colonoscopists in Canada.Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy.Accuracy of endoscopists' estimate of polyp size: A continuous dilemma.Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test.Option appraisal of population-based colorectal cancer screening programmes in England.Evaluation of a card collection-based faecal immunochemical test in screening for colorectal cancer using a two-tier reflex approachColorectal Cancer Risk Following Adenoma Removal: A Large Prospective Population-Based Cohort Study.Using a hypothetical scenario to assess public preferences for colorectal surveillance following screening-detected, intermediate-risk adenomas: annual home-based stool test vs. triennial colonoscopy.British Society of Gastroenterology/Association of Coloproctologists of Great Britain and Ireland guidelines for the management of large non-pedunculated colorectal polyps.The ADENOMA Study. Accuracy of Detection using Endocuff Vision™ Optimization of Mucosal Abnormalities: study protocol for randomized controlled trial.Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom.Survival from cancers of the colon and rectum in England and Wales up to 2001The impact of aspirin, statins and ACE-inhibitors on the presentation of colorectal neoplasia in a colorectal cancer screening programme.Long-Term Outcome and Surveillance Colonoscopy after Successful Endoscopic Treatment of Large Sessile Colorectal Polyps.Factors predictive of high-risk adenomas at the third colonoscopy after initial adenoma removal.One-year risk for advanced colorectal neoplasia: U.S. versus U.K. risk-stratification guidelinesUsing the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics.Molecular markers of carcinogenesis for risk stratification of individuals with colorectal polyps: a case-control study.Direct medical costs of care for Chinese patients with colorectal neoplasia: a health care service provider perspective.Experience with a two-tier reflex gFOBT/FIT strategy in a national bowel screening programme.The National Health Service Bowel Cancer Screening Program: the early years.The performance of routine computed tomography for the detection of colorectal cancer.Interobserver variability in assessing dysplasia and architecture in colorectal adenomas: a multicentre Canadian study.Definition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclature.A novel antibody against cancer stem cell biomarker, DCLK1-S, is potentially useful for assessing colon cancer risk after screening colonoscopy.
P2860
Q28078507-CFD84597-6ED8-438B-8911-2D71F0F8F981Q30780640-FDEF6886-E8D1-4C11-8D3C-E83D2209DD93Q33562040-82523AA4-8C55-431C-9120-39DBE3325D18Q33695329-10CE8BC7-C205-4DE2-8752-060943ACB2D0Q33770584-0A2D2667-DA05-4B76-8AC4-6A11C0A8D1DEQ33879432-5D5C78FC-4020-4751-B7B9-723B5C5357D9Q34627515-65DC6253-6981-4E71-9726-813F04421D9AQ34629542-FB1495D6-7BC0-48BE-BFE3-BE3973E3E527Q34776228-7409D86A-6577-464D-A936-5CC393C147FDQ34948953-52333211-E1B8-4918-A91B-A3AA8A10DF41Q35030521-0F0A3F17-68A7-46D6-9DD2-0FDF853FDB46Q35048575-807AFBBD-3C62-47FB-A194-4DA53FF1288EQ35177880-F7D1DCEF-D842-4A72-87C2-F7089FD5371AQ35324415-C729A1D7-F395-4B2C-A9D5-FF7608994961Q35744628-05EEFA7C-5ADE-4451-A120-336AF2894C22Q35809264-A47F5688-55B1-4B3B-BD7C-E9EC53F4B319Q35835091-2114BEA8-9A66-4699-92BE-7C80EFAC6296Q35850804-3A77852A-0CE9-485F-8390-F376235D35AFQ35889918-FCDB1C5A-ABCB-4673-BC44-D1F205783E0DQ35929500-D7E5CD8D-6027-47B3-81C2-F0A2ABA4AEA9Q36023399-D8845FCC-906A-4157-8022-24468CC46CEDQ36029617-A1CC4EDB-3049-484A-A99A-35AD2A4F6076Q36130196-FAC72CE4-1665-49B7-A0AF-1E4A5B3485A4Q36374868-554BADF3-C153-40CC-B022-5D9B70E1564BQ36572902-09EE515E-1C48-4821-8942-597701FCC0A7Q36661897-6B6CED4A-6DB8-4CFD-8B39-2803EA700464Q36917835-33D09F2D-EF2F-4CD7-BB51-654EC24797BEQ37003382-9317C5F1-68C7-4E77-BBD9-703EC19EA341Q37124760-95E54B79-4296-43D3-A104-2EC3989258D7Q37147350-B8AA734E-C45E-4557-9A7D-7533EB85F177Q37208982-B2FDFB24-534D-48A4-9ADC-D6A3B6A3260CQ37425207-A85F66AB-4C2D-462F-9BF1-002BCA97218FQ37585385-5FC043A7-5681-4468-83DB-4648AB0F2984Q37960119-DD5F4CBE-7D1A-4859-AABF-C68CF0E7E87CQ37966653-01E1EDCC-F480-43DC-BF9E-1950EDC5B4FDQ38125254-FBA6D855-A833-45F8-BE55-F7F55293A288Q38151269-D43176F7-175A-449E-A09A-B30A2E382AE3Q38227375-2DB4E673-2FF6-499C-B848-A5F1F647844BQ38246448-49FCB263-814C-4ED4-A3BA-517A0F00EB09Q38374979-8742DBC7-0EC3-4F23-81F5-50B2E053C7E0
P2860
Surveillance guidelines after removal of colorectal adenomatous polyps.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Surveillance guidelines after removal of colorectal adenomatous polyps.
@ast
Surveillance guidelines after removal of colorectal adenomatous polyps.
@en
Surveillance guidelines after removal of colorectal adenomatous polyps.
@nl
type
label
Surveillance guidelines after removal of colorectal adenomatous polyps.
@ast
Surveillance guidelines after removal of colorectal adenomatous polyps.
@en
Surveillance guidelines after removal of colorectal adenomatous polyps.
@nl
prefLabel
Surveillance guidelines after removal of colorectal adenomatous polyps.
@ast
Surveillance guidelines after removal of colorectal adenomatous polyps.
@en
Surveillance guidelines after removal of colorectal adenomatous polyps.
@nl
P2093
P2860
P1433
P1476
Surveillance guidelines after removal of colorectal adenomatous polyps.
@en
P2093
Association of Coloproctology for Great Britain and Ireland
B P Saunders
British Society for Gastroenterology
P2860
P356
10.1136/GUT.51.SUPPL_5.V6
P407
P478
51 Suppl 5
P577
2002-10-01T00:00:00Z